BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2840774)

  • 1. [Immunologic hormone detection in hypophyseal adenomas: correlation of serum hormone findings with immunocytochemical hormone levels in tumor tissue].
    Knosp E; Krisch K; Schmidbauer M; Budka H
    Wien Klin Wochenschr; 1988 May; 100(10):322-5. PubMed ID: 2840774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pituitary adenomas: serum hormone levels and immunohistochemical staining for ACTH, GH and prolactin.
    Herzog T; Schlote W; Lorenz R; Jungmann E; Althoff PH
    Clin Neuropathol; 1993; 12(2):117-20. PubMed ID: 8386600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plurihormonal pituitary adenomas.
    Scheithauer BW; Horvath E; Kovacs K; Laws ER; Randall RV; Ryan N
    Semin Diagn Pathol; 1986 Feb; 3(1):69-82. PubMed ID: 3039632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new look at pituitary adenomas: structure elucidating function.
    Sirek AM; Corenblum B; Horvath E; Rewcastle B; Ezrin C; Kovacs K
    Can Med Assoc J; 1976 Feb; 114(3):225-9. PubMed ID: 204403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A; Murray RD; Teasdale GM; Shalet SM
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of rosiglitazone--peroxisome proliferators-activated receptor gamma (PPARgamma) agonist on cell viability of human pituitary adenomas in vitro.
    Winczyk K; Kunert-Radek J; Gruszka A; Radek M; Ławnicka H; Pawlikowski M
    Neuro Endocrinol Lett; 2009 Mar; 30(1):107-10. PubMed ID: 19300395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients.
    Trouillas J; Labat-Moleur F; Sturm N; Kujas M; Heymann MF; Figarella-Branger D; Patey M; Mazucca M; Decullier E; Vergès B; Chabre O; Calender A;
    Am J Surg Pathol; 2008 Apr; 32(4):534-43. PubMed ID: 18300794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary adenomas in old Sprague-Dawley rats: a histologic, ultrastructural, and immunocytochemical study.
    McComb DJ; Kovacs K; Beri J; Zak F
    J Natl Cancer Inst; 1984 Nov; 73(5):1143-66. PubMed ID: 6092768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathology of pituitary adenomas.
    Kovacs K; Horvath E
    Bull Los Angeles Neurol Soc; 1977; 42(3-4):92-110. PubMed ID: 227505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the serum hormone levels and histological findings in pituitary adenomas.
    Irsy G; Góth M; Bálint K; Slowik F; Szabolcs I; Pásztor E; Szilágyi G
    Exp Clin Endocrinol; 1986 Dec; 88(2):224-36. PubMed ID: 3104069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pituitary tumors: hormonal status and immunohistochemical evaluation].
    Gołkowski F; Trofimiuk M; Buziak-Bereza M; Czepko R; Adamek D; Huszno B
    Przegl Lek; 2003; 60(5):338-41. PubMed ID: 14593675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subclinical adenomas of the human pituitary. New light on old problems.
    McComb DJ; Ryan N; Horvath E; Kovacs K
    Arch Pathol Lab Med; 1983 Sep; 107(9):488-91. PubMed ID: 6309114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired growth hormone secretion in patients operated for pituitary adenomas.
    Hoeck HC; Bang F; Laurberg P
    Growth Regul; 1994 Jun; 4(2):63-7. PubMed ID: 7950904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pituitary apoplexy: analysis of endocrine function in 17 cases].
    Fernández Real JM; Villabona CM; Montaña E; Acebes JJ; Ricart W; Sahún M; Gómez JM; Soler J
    Med Clin (Barc); 1991 Apr; 96(14):521-4. PubMed ID: 2051802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The human gonadotropic adenoma: pathologic diagnosis and hormonal correlations in 26 tumors.
    Trouillas J; Girod C; Sassolas G; Claustrat B
    Semin Diagn Pathol; 1986 Feb; 3(1):42-57. PubMed ID: 3112888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunohistochemistry for pituitary hormones and Ki-67 in growth hormone producing pituitary adenomas].
    Brito J; Sáez L; Lemp M; Liberman C; Michelsen H; Araya AV
    Rev Med Chil; 2008 Jul; 136(7):831-6. PubMed ID: 18949157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathological study of thyrotropin-secreting pituitary adenoma: plurihormonality and medical treatment.
    Teramoto A; Sanno N; Tahara S; Osamura YR
    Acta Neuropathol; 2004 Aug; 108(2):147-53. PubMed ID: 15185102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ultrastructural localization of pituitary hormones by immunocytochemical reactions in ultrathin sections of adenomas].
    Beckers A; Courtoy R; Reznik M; Stevenaert A; Hennen G; Boniver J
    C R Seances Soc Biol Fil; 1985; 179(3):397-402. PubMed ID: 3002569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a Novel General Pituitary Hormone Score to Evaluate the Function of the Residual Anterior Pituitary (Adenohypophysis) in Patients Following Surgery for Pituitary Adenoma.
    Wang S; Ding C; Xiao D; Wu Z; Wei L
    Med Sci Monit; 2018 Nov; 24():7944-7951. PubMed ID: 30397189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of Cushing's disease caused by pituitary adenoma producing adrenocorticotropic hormone and growth hormone concomitantly: aberrant expression of transcription factors NeuroD1 and Pit-1 as a proposed mechanism.
    Tahara S; Kurotani R; Ishii Y; Sanno N; Teramoto A; Osamura RY
    Mod Pathol; 2002 Oct; 15(10):1102-5. PubMed ID: 12379758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.